CWM
NUVB icon

Crowley Wealth Management’s Nuvation Bio NUVB Stock Holding History

Crowley Wealth Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-106,798
Closed -$395K – 236
2025
Q3 		$395K Hold
106,798
– – 0.31% 52
2025
Q2 		$208K Buy
106,798
+99,798
+1,426% +$208K 0.19% 71
2025
Q1 		$12.3K Hold
7,000
– – 0.01% 242
2024
Q4 		$18.6K Buy
+7,000
New +$18K 0.02% 211

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

Crowley Wealth Management's NUVB Position: Q4 2025 in Review

Crowley Wealth Management sold out of Nuvation Bio (NUVB) in Q4 2025, closing a stake of 106,798 shares — an estimated $395K sold.

Crowley Wealth Management first reported a position in NUVB in Q4 2024 and held it in 4 quarters. The position peaked at $395K in Q3 2025. 223 funds tracked by Wall St. Rank hold NUVB as of Q4 2025.

  • Crowley Wealth Management reported no remaining Nuvation Bio position as of Q4 2025 after selling out during the quarter.
  • Crowley Wealth Management sold 106,798 Nuvation Bio shares in Q4 2025, an estimated $395K.
  • Crowley Wealth Management first reported a position in Nuvation Bio in Q4 2024 and held it in 4 quarters.
  • Crowley Wealth Management's Nuvation Bio position peaked at $395K in Q3 2025.
  • 223 funds tracked by Wall St. Rank held Nuvation Bio as of Q4 2025.

Based on Crowley Wealth Management's 13F filing for Q4 2025.